HIV-1 Associated Neurocognitive Disorder (HAND) is commonly seen in HIV-infected patients. Viral proteins including Tat cause neuronal toxicity and is worsened by drugs of abuse. To uncover potential targets for anti-HAND therapy, we employed a literature mining system, MOLIERE. Here, we validated Dead Box RNA Helicase 3 (DDX3) as a target to treat HAND via a selective DDX3 inhibitor, RK-33. The combined neurotoxicity of Tat protein and cocaine was blocked by RK-33 in rat and mouse cortical cultures. Transcriptome analysis showed that Tat-activated transcripts include makers and regulators of microglial activation, and RK-33 blocked Tat-induced activation of these mRNAs. Elevated production of proinflammatory cytokines was also inhibited by RK-33. These findings show that DDX3 contributes to microglial activation triggered by Tat and cocaine, and DDX3 inhibition shows promise as a therapy for HAND. Moreover, DDX3 may contribute to the pathology of other neurodegenerative diseases with pathological activation of microglia.
can rapidly reveal hidden connections in the literature network (20, 21) . Machine learning approaches accelerate drug repositioning to discover new applications for existing compounds (22) . We recently developed a new AI-based literature mining system, MOLIERE which is different form many other literature-based analysis systems. The key difference is in the algorithmic pipeline and the amount of processed data. The MOLIERE do not filter the data extracted from the papers, whereas most other systems work with only highly filtered semantic objects (such as MESH terms or only genes). In addition to our own ranking methods, the algorithmic pipeline relies on several recently developed scalable machine learning methods that have not been adopted by other knowledge discovery systems such as low-dimensional representation manifold learning and scalable probabilistic topic modeling. (23, 24) . In the present article, we performed MOLIERE analysis for possible links of human proteins with HAND in the biomedical literature. This analysis revealed a previously unknown connection between HAND and Dead Box RNA Helicase 3 (DDX3) (25, 26) . DDX3 has not previously been associated with neurodegeneration related to HIV proteins, but was shown to be essential for translation of HIV proteins and the nuclear export of HIV RNA (27) . Our results show that a known inhibitor of DDX3 called RK-33, which was originally developed and tested for anti-cancer therapy (28, 29) , protects primary cortical neurons from neurotoxicity and inhibits the combined Tat plus cocaine dependent activation of microglia. The results validate DDX3 inhibition as a potential target for HAND therapy.
Results:
Literature mining to uncover targets and small molecules to test for HAND therapy.
To determine genes with yet-unknown implicit connections to HAND, we utilized MOLIERE, a system to automatically generate biomedical hypotheses (23) . The system build a multi-modal and multi-relational network of biomedical objects extracted from Medline and ULMS datasets from the National Center for Biotechnology Information .(NCBI). In the current analysis we queried the list of all human genes downloaded from HUGO (30) paired with HIV associated neurocognitive disorder. The generated hypotheses were ranked based on a number of techniques described in (24) . The hypotheses ranking represent the level of association each gene has with HAND. The genes were categorized as "Trivial" (top 2.5% genes with exceptionally high ranking scores typical of well-explored prior connections clearly associated with HAND), "High Potential" (next 15% of genes), "Low Potential" (next 15% of genes) and "Random" ( Fig   1A) . To determine the availability of small molecule inhibitors for "High Potential" category gene products, the genes were queried through a protein-small molecule interaction database, BindingDB (31) . About 180 proteins out of 4450 genes have at least one associated small molecule ( Fig 1B, Supplemental Table 1 ). Next, the list of the genes was narrowed by the selection of small molecule inhibitors that have been tested in animals and did not manifest any significant systemic toxicity at therapeutic concentrations. The search of the literature revealed 52 protein-small molecule pairs (Fig 1D, Supplemental Table 1 ). From the short list we selected RK-33, an inhibitor of Dead Box RNA Helicase 3 (DDX3) for experimental evaluation for the following reasons: RK-33 was shown to be a very selective inhibitor of DDX3 ATPase activity; the compound was active in vitro in nanomolar concentrations, and in micromolar concentrations in cell culture and animal models; and it was easily available commercially. Lastly, it had been extensively tested in rodents and did not show any systemic toxicity (28, 29) . Although DDX3 had never been associated with HAND, it was shown to be important for HIV infection (27) , specifically by exporting viral RNA from nucleus to cytoplasm (32) .
RK-33 protects neurons in primary cortical cultures from the combined neurotoxicity of HIV-Tat and cocaine.
To test the hypothesis that inhibition of DDX3 has neuroprotective effects in a model of HAND, we used a well-established cell culture model of rodent primary cortical neurons co-treated with Tat and cocaine in previously established concentration ranges (33) (34) (35) (36) (37) . In this system, the addition of Tat at a low (6 ng/ml) or high (60 ng/ml) concentration, or cocaine (10 µM or 25 µM) individually did not significantly induce the death of primary neurons during 72 h of treatment ( Fig   1C, D) . However, pre-treatment with Tat for 48 h followed by the addition of cocaine for another 24 h (Fig 2A, B) drastically increased neuronal death, as measured by activated Caspase 3/7 signal and nuclear localization of ethidium bromide homodimer (Fig 1C, D) . Strikingly, treatment with the DDX3 inhibitor RK-33 at 6 µM resulted in a 50%-80% reduction of neuronal death caused by Tat and cocaine co-treatment (Fig 1C, D) . The initial 6 µM concentration of RK-33 selected was similar to that used previously (29) . RK-33 protected rat neurons from Tat/cocaine toxicity in a dose dependent manner starting as low as 1 µM (Fig 1E) , which was comparable with RK-33 bioactivity observed in other cell-based assays (29, 38) . Nearly identical qualitative results were observed with a mouse primary neuron cortical culture regarding Tat/cocaine damage and RK-33 mediated protection from damage (Supplemental Figure S1) . A notable quantitative difference was that rat primary neurons appear to be much more sensitive to cocaine relative to the mouse neurons, because a 10-fold lower cocaine dose was used to promote neuronal apoptosis in combination with Tat. Hence, the results in both rat and mouse cortical cultures show that DDX3 inhibition is neuroprotective against the combined insult of Tat and cocaine.
RNA-seq transcriptomic profiling of RK-33 effects on Tat-treated cortical cultures.
To explore the mechanism of RK-33 neuroprotection seen above, we performed RNA sequencing (RNA-seq) of the primary cortical cultures treated with Tat in the presence or absence of RK-33.
We found differential expression of 547 genes in Tat-treated cultures compared to control (Adjusted FDR, P<0.05). Hierarchical clustering revealed that Tat-dependent upregulation of 211 genes was inhibited by RK-33 (adjusted FDR P< 0.05 for 83 genes) (Fig 2A-B Table S2 ).
Pathway enrichment analysis of Tat-regulated genes shows that proinflammatory pathways, such as "Complement Cascade", "Neutrophil Dysregulation" and "Cytokine Signaling" are significantly enriched, as noted by the comparisons between Tat vs control ( Fig 2B, Supplemental Figure S3 ).
In the major brain cell types (neurons, astrocytes, oligodendrocytes, epithelial and microglial cells), these pathways are known to be associated with activated microglia (39) (40) (41) . Notably, the expression of these same genes was suppressed by RK-33 treatment (Fig 2B, Supplemental   Figure S3 ). Among this subset of genes upregulated by Tat alone and sensitive to RK-33 the following are worth noting: complement components C1qa, C1qc, C1qb; bona fide markers of microglial cells such as ionized calcium binding adaptor molecule 1 (Iba1 or AIf1), integrin Cd11a/b (Itgam), Ptprc (CD45); Colony-stimulating factor-1 (CSF-1) and granulocyte colonystimulating factor (g-CSF) receptors, Csf1r and Csf3r, which are necessary for microglial survival and proliferation (42) (Fig 3D) . Further, gene set enrichment analysis (GSEA) (43) with custom databases of genes enriched in brain cell subtypes as defined by RNA-seq Transcriptome and splicing databases of the cerebral cortex (44) shows significant enrichment of microgliaassociated genes in Tat-regulated and RK-33 sensitive, Tat -regulated genes (Fig 2D, Supplemental Figure S4 ).
Taken together, the results of the RNA-seq analysis demonstrates that, in agreement with a previous publication (45) , Tat triggers the expression of genes associated with activated microglia. Moreover, this activation is inhibited by RK-33. These same genes found by RNA-seq to be regulated by HIV-Tat treatment are also found in the high-ranked genes subset of HANDassociated genes from the MOLIERE analysis (p<0.0025), including Csf1r. (Fig 3A, B) . These results were confirmed with CD11b/c, which is expressed in resting microglia and is greatly elevated upon activation (49, 50) Collectively, these results are the first to connect DDX3 to the activation of microglia.
Moreover, the DDX3 inhibitor RK-33 inhibits Tat/cocaine-dependent microglial activation, which both implicates DDX3 in this pathogenesis and also suggests it is a viable target for treatment of HAND and potentially other neurocognitive diseases in which activated microglia play a role. The mechanism of DDX3-dependent regulation of microglia activation remains to be determined.
However, recent results regarding the function of DDX3 in the regulation of a macrophage inflammatory response may shed light on DDX3 activity in neuroinflammation. HIV proteins activate the secretion of chemokines and cytokines by microglia cells through NF-κB, p38 and TGF-β pathways (56) (57) (58) (59) . The small GTPase Rac1 was shown to be a regulator activating morphological changes in microglia cells (60, 61) . These pathways are well known to control the inflammatory response, cytokine secretion, and migration of macrophages. Importantly, it was recently shown that DDX3 directly regulates the translation of p38 MAPK, Rac1, STAT1 (TGF-β) and TAK1, which play essential roles in NF-κB regulation (38) . The direct role of DDX3 in regulating pro-inflammatory responses in the pathogenesis of bowel disease and Listeria infection were also recently observed (62, 63) . Inhibition of DDX3 activity stalled the translation of target proteins (38, 64) , resulting in a decrease of cytokine secretion and inhibition of macrophage migration and phagocytosis (38) . It therefore appears plausible that DDX3-dependent translational control may be the mechanism that regulates microglial activation in neuroinflammatory pathways. Experiments are ongoing to formally test this.
As mentioned previously, DDX3 has been proposed as a target for development of antiviral and anti-HIV therapy (65, 66) (67-70). This makes DDX3 a unique target, in which inhibition may affect both HIV-related neurotoxicity and the production of viral proteins by glial cells.
However, the contribution of DDX3 to innate immunity has to be fully evaluated prior to clinical advancement of DDX3 inhibitors for HAND therapy (27, 71) . Nonetheless, DDX3-specific inhibition as a target and RK-33 as a prototype molecule for the development of HAND therapy has been validated and should be investigated further. Moreover, given the importance of microglial activation in the pathology of other neurodegenerative diseases, DDX3 targeting could be applicable for the treatment of other neurodegenerative diseases.
Materials and Methods

MOLIERE Analysis
The implementation and documentation are available at https://github.com/JSybrandt/MOLIERE.
The repository also contains list of all software dependencies to packages to compute approximate nearest neighbor graphs, low-dimensional embeddings, probabilistic topic modeling, phrase mining, and graph algorithms. The repository is organized in two major sub-projects, namely, build_network and run_query, each contains its own documentation. Preinstallation dependencies include gcc 5.4 or greater, Python 3, Java 1.8, Scons, Google Test , and Mpich 3.1.4. It is recommended to use parallel machines, as many components of the project are parallelized being too slow if executed in sequential mode. The input to the phase of building the knowledge network requires downloading full MEDLINE and UMLS. Building the network is also possible with partial MEDLINE if one wants to restrict the information domain in order to increase speed. Most algorithmic components require parameters that are provided with the code. When the knowledge network is constructed, the second phase consists of running queries using run query subproject. Running all queries, each of type gene-HAND, can be done in parallel, as all of them are independent. Each query will return the hypotheses in a form of topic model, i.e., a distribution of most representative keywords per learned topic, as well as a ranking score. In addition, the result of each single query can be visualized for further analysis using the visualization sub-project that can be found in the same repository. The visualization connects all learned topics in a network, where nodes correspond to topics, and edges represent mutual content connections. Clicking each node will bring up the most relevant to the corresponding paper topics as well as the most representative topical keywords.
Here we describe the datasets used in knowledge network construction and querying MEDLINE, the NLM database of biomedical abstracts, releases public yearly baselines. We used the 2017 baseline, published early that year, which was the most up-to-date at the time. This dataset consists of 26,759,399 documents; however, we found that certain short documents hinder hypothesis generation results. Therefore, we removed any document that is fewer than 20 words that also does not contain at least two "rare" words found in the bottom 85% most frequent words.
The Unified Medical Language System (UMLS) consists of known medical entities, as well as their synonyms and relationships. This NLM dataset releases every six months, and we used the GRCm38.p5 (GCA_000001635.7, ensemble release-88) using STAR v2.4 (72) . Samtools (v1.2) was used to convert aligned sam files to bam files, and reads were counted using the featureCounts function of the Subreads package (73) with Gencode.vM19.basic.annotation.gtf annotation file. Only reads that were mapped uniquely to the genome were used for gene expression analysis. Differential expression analysis was performed in R using the edgeR package (74) . The average read depth for the samples was around 15 million reads, and only genes with at least one count per million average depth were considered for differential expression analysis. Raw counts were normalized using the Trimmed Mean of M-values (TMM) method. The normalized read counts were fitted to a quasi-likelihood negative binomial generalized log-linear model using the function glmQLFit, and genewise statistical tests for significant differential expression were conducted with empirical Bayes quasi-likelihood F-tests using the function glmQLFTest.
Pathway enrichment and GSEA analysis.
Pathway enrichment of HIV-Tat and RK-33 regulated genes were analyzed using Enrichr (75) Table S3 ). Overrepresentation of Tat-activated genes in MOLIERE-selected subset were identified using hypergeometric distribution test.
Preparation and cultivation of primary cortical cultures.
Primary cortical cell cultures were prepared from 18-day-old Sprague-Dawley (Envigo Laboratories, Indianapolis, IN) rat fetuses or from 18-day-old C57BL/6 mouse fetuses as previously described (76, Representation of ranking distribution of the ~27,000 HUGO genes. The ranked hypotheses representing the level of association of each gene with HAND were categorized as following: "Trivial" (top 2.5% genes with exceptionally high ranking scores typical of wellexplored prior connections clearly associated with HAND), "High Potential" (next 15% of genes), "Low Potential" (next 15% of genes) and "Random" (A).
Representative selection of genes for experimental validation, from all the "high potential genes" to genes with known small molecule ligands that have already tested safe for animal toxicity (B).
Primary cortical cultures were treated with Tat (6 or 60 ng/ml) and/or cocaine (10 or 25 µM) or Tat combined with a range of RK-33 for 48 h prior to the addition of cocaine for another 24 h. Cultures were then fixed with 4% PFA and the dead/apoptotic cells were detected using CellEvent Caspase 3/7 Assay Kit (C: green, Caspase 3/7; red, Ethidium Bromide. Scale bar, 100 µm).
Tat and/or cocaine only treatments are colored in green, and the deepening blue hue represents the increasing concentration of RK-33 (from 0.25 to 12 µM) (D).
The bar graph shows Tat and/or cocaine only treatments in light blue and RK-33 in dark blue (E). The bar heights indicate mean values and error bars indicate one sample standard error from the sample mean. Each point corresponds to an image, with each image containing a range of 60-100 cells. The Mann-Whitney-Wilcoxon test is conducted to calculate the statistical significance, followed by Benjamini-Hochberg adjustment of p-values (*, p<0.05; **, p<0.01; ***, P<0.0001). Cortical cultures were treated in triplicates with Tat (60 ng/ml), RK-33 (6 µM), combination of Tat (60 ng/ml) and RK-33 (6 µM) and then were compared with untreated cultures. RNA-seq transcriptomics profiling was performed as described (see Materials and Methods for details).
Hierarchical clustering of log transformed counts per millions for genes differentially regulated by Tat treatment (p<0.0005) (A).
Volcano plot comparing gene expression of control vs Tat Cortical cultures were treated with Tat alone (6 or 60 ng/ml) or Tat combined with RK-33 (6 µM) for 48 h prior to addition of cocaine (10 or 25 µM) for another 24 h. Cultures were then fixed with 4% PFA, and microglial cells were detected using anti-Iba1 and anti-CD11b/c antibodies as described in Materials and Methods. The number of microglial cells increased when cultured cells were subjected to Tat alone or cocaine alone, and especially, when Tat was combined with cocaine, producing a dramatic increase of activated microglia in the cortical cell cultures (A: blue, DAPI; green, Iba1. Scale bar, 250 µm. C: blue, DAPI; purple, CD11b/c. Scale bar, 100 µm).
The box-and-whisker plot graphs Tat and/or cocaine only treatments in light blue and the addition of RK-33 in dark blue (B, D) . The boxes cover 50% of data in each condition, and the lines within the boxes indicate the median values. The Mann-Whitney-Wilcoxon test was conducted to calculate the statistical significance, followed by Benjamini-Hochberg adjustment of p-values (*, p<0.05; **, p<0.01; ***, p<0.001). Cortical cultures were treated with Tat (6 or 60 ng/ml) and/or cocaine (25 µM) alone or Tat combined with RK-33 (6 µM) for 48 h prior to addition of cocaine for another 24 h. Conditioned media were collected from each sample, cultures were then fixed with 4% PFA and microglial cells were detected using anti-Iba1, anti-CD11b/c, and anti-MAP2 antibodies as described in Materials and Methods. The area of microglial cells was quantified using ImageJ (A: blue, DAPI; green, Iba1; red, MAP2. Scale bar, 50 µm).
The box-and-whisker plot graphs Tat and/or cocaine only treatments in light blue and RK-33 in dark blue (B). The boxes cover 50% of data in each condition, and the lines within the boxes indicate the median values. Each point corresponds to an image field, with each image covering a range of 60-100 cells. The Mann-Whitney-Wilcoxon test was conducted to calculate the statistical significance, followed by Benjamini-Hochberg adjustment of p-values (*, p<0.05; **, p<0.01; ***, p<0.001).
(C) Cortical cultures were treated as above with Tat (60 ng/ml) and/or cocaine (25 µM) alone or Tat combined with RK-33 (6 µM). The cytokine levels were determined by 8-plex chemokine/cytokine array. Bars represent chemokine/cytokine concentrations in the medium (pg/ml). (*) indicates the concentration below the detection limit. 
